Follow the people · Insider
Mark G. Foletta
Mark G. Foletta files insider transactions with the SEC as a director of Dexcom (DXCM). We hold 4 disclosed purchases and sales filed since 18 January 2006, 4 of them in the last 90 days.
- Files forDXCM
- Disclosed buys and sells4 in all, 4 in the last 90 days
- Last disclosure4 August 2026
Positions held
11 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 17 November 2014 — 3 August 2026Director · Dexcom (DXCM)127 Form 4 lines · source: SEC Form 4
- Filed 15 December 2016 — 15 June 2026Director · Amn Healthcare Services (AMN)41 Form 4 lines · source: SEC Form 4
- Filed 29 June 2020 — 11 March 2026Director · Enanta Pharmaceuticals (ENTA)8 Form 4 lines · source: SEC Form 4
- Filed 19 April 2017 — 4 October 2019EVP & Chief Financial Officer · Tocagen (TOCA)7 Form 4 lines · source: SEC Form 4
- Filed 30 January 2013 — 4 December 2017Director · Regulus Therapeutics (RGLS)7 Form 4 lines · source: SEC Form 4
- Filed 10 December 2012 — 20 April 2016Director · Amn Healthcare Services (AHS)7 Form 4 lines · source: SEC Form 4
- Filed 31 August 2015 — 31 August 2015Interim CFO · Biocept (BIOC)1 Form 4 line · source: SEC Form 4
- Filed 23 January 2014 — 10 November 2014Director · Ambit Biosciences (AMBI)4 Form 4 lines · source: SEC Form 4
- Filed 22 May 2014 — 22 May 2014Director · Regulus Therapeutics ("""RGLS""")1 Form 4 line · source: SEC Form 4
- Filed 17 January 2006 — 8 August 2012SVP, Chief Financial Officer · Amylin Pharmaceuticals (AMLN)161 Form 4 lines · source: SEC Form 4
- Filed 2 June 2006 — 27 May 2011Director · Anadys Pharmaceuticals (ANDS)8 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 2,000 shares of DexcomSEC Form 44 August 2026Common Stock · traded 31 July 2026 · filed 4 August 2026
- ▼ sold on the open market 2,000 shares of DexcomSEC Form 44 August 2026Common Stock · traded 3 August 2026 · filed 4 August 2026
- ▼ sold on the open market 3,801 shares of DexcomSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- ▼ sold on the open market 199 shares of DexcomSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- ▼ sold on the open market 1,681 shares of Amn Healthcare ServicesSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- ▼ sold on the open market 2,000 shares of Amn Healthcare ServicesSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- was granted 6,331 shares of DexcomSEC Form 41 June 2026Common Stock · traded 28 May 2026 · filed 1 June 2026
- gave away 5,731 shares of DexcomSEC Form 411 May 2026Common Stock · traded 8 May 2026 · filed 11 May 2026
- gave away 5,731 shares of DexcomSEC Form 411 May 2026Common Stock · traded 8 May 2026 · filed 11 May 2026
- exercised options over 8,325 shares of Amn Healthcare ServicesSEC Form 44 May 2026Common Stock · traded 1 May 2026 · filed 4 May 2026
- exercised options over 8,325 shares of Amn Healthcare Services (a derivative holding)SEC Form 44 May 2026Restricted Stock Units · traded 1 May 2026 · filed 4 May 2026
- was granted 8,304 shares of Amn Healthcare Services (a derivative holding)SEC Form 44 May 2026Restricted Stock Units · traded 1 May 2026 · filed 4 May 2026
- was granted 20,000 shares of Enanta Pharmaceuticals (a derivative holding)SEC Form 413 March 2026Stock Option (right to buy) · traded 11 March 2026 · filed 13 March 2026
- was granted 20,000 shares of Enanta Pharmaceuticals (a derivative holding)SEC Form 413 March 2026Stock Option (right to buy) · traded 11 March 2026 · filed 13 March 2026
- ▼ sold on the open market 2,555 shares of DexcomSEC Form 418 August 2025Common Stock · traded 15 August 2025 · filed 18 August 2025
- ▼ sold on the open market 195 shares of DexcomSEC Form 418 August 2025Common Stock · traded 15 August 2025 · filed 18 August 2025
- ▼ sold on the open market 2,742 shares of DexcomSEC Form 417 July 2025Common Stock · traded 15 July 2025 · filed 17 July 2025
- ▼ sold on the open market 8 shares of DexcomSEC Form 417 July 2025Common Stock · traded 15 July 2025 · filed 17 July 2025
- ▼ sold on the open market 2,750 shares of DexcomSEC Form 418 June 2025Common Stock · traded 16 June 2025 · filed 18 June 2025
- gave away 2,973 shares of DexcomSEC Form 412 May 2025Common Stock · traded 8 May 2025 · filed 12 May 2025
- gave away 2,973 shares of DexcomSEC Form 412 May 2025Common Stock · traded 8 May 2025 · filed 12 May 2025
- was granted 5,731 shares of DexcomSEC Form 412 May 2025Common Stock · traded 8 May 2025 · filed 12 May 2025
- was granted 8,325 shares of Amn Healthcare Services (a derivative holding)SEC Form 46 May 2025Restricted Stock Units · traded 2 May 2025 · filed 6 May 2025
- exercised options over 3,019 shares of Amn Healthcare Services (a derivative holding)SEC Form 421 April 2025Restricted Stock Units · traded 19 April 2025 · filed 21 April 2025
- exercised options over 3,019 shares of Amn Healthcare ServicesSEC Form 421 April 2025Common Stock · traded 19 April 2025 · filed 21 April 2025
- was granted 15,700 shares of Enanta Pharmaceuticals (a derivative holding)SEC Form 414 March 2025Stock Option (right to buy) · traded 13 March 2025 · filed 14 March 2025
- ▼ sold on the open market 7 shares of DexcomSEC Form 420 June 2024Common Stock · traded 17 June 2024 · filed 20 June 2024
- ▼ sold on the open market 2,212 shares of DexcomSEC Form 420 June 2024Common Stock · traded 17 June 2024 · filed 20 June 2024
- ▼ sold on the open market 475 shares of DexcomSEC Form 420 June 2024Common Stock · traded 17 June 2024 · filed 20 June 2024
- ▼ sold on the open market 3,007 shares of DexcomSEC Form 420 June 2024Common Stock · traded 18 June 2024 · filed 20 June 2024
- ▼ sold on the open market 299 shares of DexcomSEC Form 420 June 2024Common Stock · traded 18 June 2024 · filed 20 June 2024
- was granted 2,973 shares of DexcomSEC Form 424 May 2024Common Stock · traded 22 May 2024 · filed 24 May 2024
- gave away 3,306 shares of DexcomSEC Form 421 May 2024Common Stock · traded 18 May 2024 · filed 21 May 2024
- gave away 3,306 shares of DexcomSEC Form 421 May 2024Common Stock · traded 18 May 2024 · filed 21 May 2024
- exercised options over 1,681 shares of Amn Healthcare Services (a derivative holding)SEC Form 423 April 2024Restricted Stock Units · traded 19 April 2024 · filed 23 April 2024
- was granted 3,019 shares of Amn Healthcare Services (a derivative holding)SEC Form 423 April 2024Restricted Stock Units · traded 19 April 2024 · filed 23 April 2024
- exercised options over 1,681 shares of Amn Healthcare ServicesSEC Form 423 April 2024Common Stock · traded 19 April 2024 · filed 23 April 2024
- was granted 15,700 shares of Enanta Pharmaceuticals (a derivative holding)SEC Form 48 March 2024Stock Option (right to buy) · traded 6 March 2024 · filed 8 March 2024
- ▲ bought on the open market 500 shares of Amn Healthcare ServicesSEC Form 41 March 2024Common Stock · traded 29 February 2024 · filed 1 March 2024
- was granted 3,306 shares of DexcomSEC Form 422 May 2023Common Stock · traded 18 May 2023 · filed 22 May 2023
- gave away 4,488 shares of DexcomSEC Form 422 May 2023Common Stock · traded 18 May 2023 · filed 22 May 2023
- gave away 4,488 shares of DexcomSEC Form 422 May 2023Common Stock · traded 18 May 2023 · filed 22 May 2023
- exercised options over 1,681 shares of Amn Healthcare Services (a derivative holding)SEC Form 419 May 2023Restricted Stock Units · traded 17 May 2023 · filed 19 May 2023
- exercised options over 1,458 shares of Amn Healthcare Services (a derivative holding)SEC Form 425 April 2023Restricted Stock Units · traded 21 April 2023 · filed 25 April 2023
- exercised options over 1,458 shares of Amn Healthcare ServicesSEC Form 425 April 2023Common Stock · traded 21 April 2023 · filed 25 April 2023
- ▼ sold on the open market 1,458 shares of Amn Healthcare ServicesSEC Form 425 April 2023Common Stock · traded 21 April 2023 · filed 25 April 2023
- ▼ sold on the open market 4,989 shares of Amn Healthcare ServicesSEC Form 413 April 2023Common Stock · traded 11 April 2023 · filed 13 April 2023
- ▼ sold on the open market 1,053 shares of Amn Healthcare ServicesSEC Form 413 April 2023Common Stock · traded 11 April 2023 · filed 13 April 2023
- was granted 10,800 shares of Enanta Pharmaceuticals (a derivative holding)SEC Form 46 March 2023Stock Option (right to buy) · traded 2 March 2023 · filed 6 March 2023
- gave away 300 shares of Amn Healthcare ServicesSEC Form 416 December 2022Common Stock · traded 15 November 2022 · filed 16 December 2022
- acquired or disposed of, other 1,054 shares of DexcomSEC Form 423 May 2022Common Stock · traded 19 May 2022 · filed 23 May 2022
- was granted 1,122 shares of DexcomSEC Form 423 May 2022Common Stock · traded 20 May 2022 · filed 23 May 2022
- acquired or disposed of, other 1,054 shares of DexcomSEC Form 423 May 2022Common Stock · traded 19 May 2022 · filed 23 May 2022
- exercised options over 2,139 shares of Amn Healthcare Services (a derivative holding)SEC Form 422 April 2022Restricted Stock Units · traded 21 April 2022 · filed 22 April 2022
- was granted 1,458 shares of Amn Healthcare Services (a derivative holding)SEC Form 422 April 2022Restricted Stock Units · traded 21 April 2022 · filed 22 April 2022
- exercised options over 2,139 shares of Amn Healthcare ServicesSEC Form 422 April 2022Common Stock · traded 21 April 2022 · filed 22 April 2022
- was granted 7,500 shares of Enanta Pharmaceuticals (a derivative holding)SEC Form 47 March 2022Stock Option (right to buy) · traded 3 March 2022 · filed 7 March 2022
- ▼ sold on the open market 41 shares of DexcomSEC Form 42 December 2021Common Stock · traded 1 December 2021 · filed 2 December 2021
- ▼ sold on the open market 70 shares of DexcomSEC Form 42 December 2021Common Stock · traded 1 December 2021 · filed 2 December 2021
- ▼ sold on the open market 78 shares of DexcomSEC Form 42 December 2021Common Stock · traded 1 December 2021 · filed 2 December 2021
- ▼ sold on the open market 116 shares of DexcomSEC Form 42 December 2021Common Stock · traded 1 December 2021 · filed 2 December 2021
- ▼ sold on the open market 65 shares of DexcomSEC Form 42 December 2021Common Stock · traded 1 December 2021 · filed 2 December 2021
- ▼ sold on the open market 87 shares of DexcomSEC Form 42 December 2021Common Stock · traded 1 December 2021 · filed 2 December 2021
- ▼ sold on the open market 2 shares of DexcomSEC Form 42 December 2021Common Stock · traded 1 December 2021 · filed 2 December 2021
- ▼ sold on the open market 41 shares of DexcomSEC Form 42 December 2021Common Stock · traded 1 December 2021 · filed 2 December 2021
- ▼ sold on the open market 45 shares of DexcomSEC Form 42 November 2021Common Stock · traded 1 November 2021 · filed 2 November 2021
- ▼ sold on the open market 14 shares of DexcomSEC Form 42 November 2021Common Stock · traded 1 November 2021 · filed 2 November 2021
- ▼ sold on the open market 13 shares of DexcomSEC Form 42 November 2021Common Stock · traded 1 November 2021 · filed 2 November 2021
- ▼ sold on the open market 43 shares of DexcomSEC Form 42 November 2021Common Stock · traded 1 November 2021 · filed 2 November 2021
- ▼ sold on the open market 124 shares of DexcomSEC Form 42 November 2021Common Stock · traded 1 November 2021 · filed 2 November 2021
- ▼ sold on the open market 7 shares of DexcomSEC Form 42 November 2021Common Stock · traded 1 November 2021 · filed 2 November 2021
- ▼ sold on the open market 56 shares of DexcomSEC Form 42 November 2021Common Stock · traded 1 November 2021 · filed 2 November 2021
- ▼ sold on the open market 76 shares of DexcomSEC Form 42 November 2021Common Stock · traded 1 November 2021 · filed 2 November 2021
- ▼ sold on the open market 42 shares of DexcomSEC Form 42 November 2021Common Stock · traded 1 November 2021 · filed 2 November 2021
- ▼ sold on the open market 40 shares of DexcomSEC Form 42 November 2021Common Stock · traded 1 November 2021 · filed 2 November 2021
- ▼ sold on the open market 40 shares of DexcomSEC Form 42 November 2021Common Stock · traded 1 November 2021 · filed 2 November 2021
- ▼ sold on the open market 47 shares of DexcomSEC Form 45 October 2021Common Stock · traded 1 October 2021 · filed 5 October 2021
- ▼ sold on the open market 6 shares of DexcomSEC Form 45 October 2021Common Stock · traded 1 October 2021 · filed 5 October 2021
- ▼ sold on the open market 88 shares of DexcomSEC Form 45 October 2021Common Stock · traded 1 October 2021 · filed 5 October 2021
- ▼ sold on the open market 126 shares of DexcomSEC Form 45 October 2021Common Stock · traded 1 October 2021 · filed 5 October 2021
- ▼ sold on the open market 181 shares of DexcomSEC Form 45 October 2021Common Stock · traded 1 October 2021 · filed 5 October 2021
- ▼ sold on the open market 51 shares of DexcomSEC Form 45 October 2021Common Stock · traded 1 October 2021 · filed 5 October 2021
- ▼ sold on the open market 1 share of DexcomSEC Form 45 October 2021Common Stock · traded 1 October 2021 · filed 5 October 2021
- ▼ sold on the open market 2,500 shares of Amn Healthcare ServicesSEC Form 415 June 2021Common Stock · traded 11 June 2021 · filed 15 June 2021
- acquired or disposed of, other 895 shares of DexcomSEC Form 425 May 2021Common Stock · traded 20 May 2021 · filed 25 May 2021
- was granted 1,054 shares of DexcomSEC Form 425 May 2021Common Stock · traded 21 May 2021 · filed 25 May 2021
- acquired or disposed of, other 895 shares of DexcomSEC Form 425 May 2021Common Stock · traded 20 May 2021 · filed 25 May 2021
- exercised options over 2,826 shares of Amn Healthcare ServicesSEC Form 423 April 2021Common Stock · traded 21 April 2021 · filed 23 April 2021
- exercised options over 2,826 shares of Amn Healthcare Services (a derivative holding)SEC Form 423 April 2021Restricted Stock Units · traded 21 April 2021 · filed 23 April 2021
- was granted 2,139 shares of Amn Healthcare Services (a derivative holding)SEC Form 423 April 2021Restricted Stock Units · traded 21 April 2021 · filed 23 April 2021
- was granted 7,500 shares of Enanta Pharmaceuticals (a derivative holding)SEC Form 44 March 2021Stock Option (right to buy) · traded 2 March 2021 · filed 4 March 2021
- ▼ sold on the open market 15 shares of DexcomSEC Form 418 November 2020Common Stock · traded 16 November 2020 · filed 18 November 2020
- ▼ sold on the open market 139 shares of DexcomSEC Form 418 November 2020Common Stock · traded 16 November 2020 · filed 18 November 2020
- ▼ sold on the open market 117 shares of DexcomSEC Form 418 November 2020Common Stock · traded 16 November 2020 · filed 18 November 2020
- ▼ sold on the open market 428 shares of DexcomSEC Form 418 November 2020Common Stock · traded 16 November 2020 · filed 18 November 2020
- ▼ sold on the open market 301 shares of DexcomSEC Form 418 November 2020Common Stock · traded 16 November 2020 · filed 18 November 2020
- ▼ sold on the open market 42 shares of DexcomSEC Form 419 October 2020Common Stock · traded 15 October 2020 · filed 19 October 2020
- ▼ sold on the open market 120 shares of DexcomSEC Form 419 October 2020Common Stock · traded 15 October 2020 · filed 19 October 2020
- ▼ sold on the open market 255 shares of DexcomSEC Form 419 October 2020Common Stock · traded 15 October 2020 · filed 19 October 2020
- ▼ sold on the open market 375 shares of DexcomSEC Form 419 October 2020Common Stock · traded 15 October 2020 · filed 19 October 2020
- ▼ sold on the open market 208 shares of DexcomSEC Form 419 October 2020Common Stock · traded 15 October 2020 · filed 19 October 2020
- ▼ sold on the open market 3 shares of DexcomSEC Form 416 September 2020Common Stock · traded 14 September 2020 · filed 16 September 2020
- ▼ sold on the open market 109 shares of DexcomSEC Form 416 September 2020Common Stock · traded 14 September 2020 · filed 16 September 2020
- ▼ sold on the open market 200 shares of DexcomSEC Form 416 September 2020Common Stock · traded 14 September 2020 · filed 16 September 2020
- ▼ sold on the open market 231 shares of DexcomSEC Form 416 September 2020Common Stock · traded 14 September 2020 · filed 16 September 2020
- ▼ sold on the open market 222 shares of DexcomSEC Form 416 September 2020Common Stock · traded 14 September 2020 · filed 16 September 2020
- ▼ sold on the open market 121 shares of DexcomSEC Form 416 September 2020Common Stock · traded 14 September 2020 · filed 16 September 2020
- ▼ sold on the open market 114 shares of DexcomSEC Form 416 September 2020Common Stock · traded 14 September 2020 · filed 16 September 2020
- was granted 17,000 shares of Enanta Pharmaceuticals (a derivative holding)SEC Form 41 July 2020Stock Option (right to buy) · traded 29 June 2020 · filed 1 July 2020
- acquired or disposed of, other 3,055 shares of DexcomSEC Form 427 May 2020Common Stock · traded 21 May 2020 · filed 27 May 2020
- was granted 895 shares of DexcomSEC Form 427 May 2020Common Stock · traded 22 May 2020 · filed 27 May 2020
- acquired or disposed of, other 3,055 shares of DexcomSEC Form 427 May 2020Common Stock · traded 21 May 2020 · filed 27 May 2020
- was granted 2,826 shares of Amn Healthcare Services (a derivative holding)SEC Form 424 April 2020Restricted Stock Units · traded 22 April 2020 · filed 24 April 2020
- exercised options over 2,907 shares of Amn Healthcare Services (a derivative holding)SEC Form 421 April 2020Restricted Stock Units · traded 17 April 2020 · filed 21 April 2020
- exercised options over 2,907 shares of Amn Healthcare ServicesSEC Form 421 April 2020Common Stock · traded 17 April 2020 · filed 21 April 2020
- ▼ sold on the open market 107 shares of DexcomSEC Form 44 March 2020Common Stock · traded 3 March 2020 · filed 4 March 2020
- ▼ sold on the open market 152 shares of DexcomSEC Form 44 March 2020Common Stock · traded 3 March 2020 · filed 4 March 2020
- ▼ sold on the open market 81 shares of DexcomSEC Form 44 March 2020Common Stock · traded 3 March 2020 · filed 4 March 2020
- ▼ sold on the open market 155 shares of DexcomSEC Form 44 March 2020Common Stock · traded 3 March 2020 · filed 4 March 2020
- ▼ sold on the open market 114 shares of DexcomSEC Form 44 March 2020Common Stock · traded 3 March 2020 · filed 4 March 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.